For the new study, researchers recruited 518 patients with advanced triple-positive breast cancer across 109 hospitals in the U.S., Europe, New Zealand and Australia between June 2017 and July 2021.

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

It’s not often that researchers get to share encouraging news when it comes to cancer. That’s why the recent announcement ...

Good news in the fight against cancer: Survival rates in the United States are improving, a new report shows. In the annual report from the American Cancer Society, out Jan. 13, findings showed 7 in ...

Pennsylvania has seen improvement over the past five years in the diagnosis rate and survivability of lung cancer, but more can be done. These are among the trends examined in the American Lung ...

Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a new report shows where we stand in fighting against the disease, including in ...

HER2-positive breast cancer is driven by HER2 protein overexpression, historically linked to poor outcomes but now improved by targeted therapies. Treatment varies by stage, involving surgery, ...